NCT03827408View on ClinicalTrials.gov

Nebulized Midazolam, Dexmedetomidine, and Their Combination in Sedation of Preschoolers Undergoing Dental Treatment

PHASE2CompletedINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

November 27, 2017

Primary Completion Date

August 29, 2019

Study Completion Date

December 22, 2019

Conditions
Dental Anxiety
Interventions
DRUG

Midazolam group (MDZ)

IV Ampules of Dormicum 15mg/ 3ml, Hoffman-La Rouche Ltd., Basel, Switzerland

DRUG

Dexmedetomidine group (DEX)

IV Ampules of Precedex 4mcg/ml, Hospira. Inc., Lake Forest,IL USA.

DRUG

Combination of Midazolam and Dexmedetomidine (MDZ/DEX)

Combination of Nebulized solution of 0.3 mg/kg Midazolam, and 3µg/kg Dexmedetomidine respectively.(

Trial Locations (1)

21512

Faculty of Dentistry, Alexandria University, Alexandria

All Listed Sponsors
collaborator

Alexandria University

OTHER

lead

Nourhan M.Aly

OTHER

NCT03827408 - Nebulized Midazolam, Dexmedetomidine, and Their Combination in Sedation of Preschoolers Undergoing Dental Treatment | Biotech Hunter | Biotech Hunter